![]() Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa. | ![]() Cell Signaling Technology Cell Signaling Technology develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents. | ||||
Founding Date | Founding Date 1989 | Founding Date 1986 | Founding Date 1999 | Founding Date 1961 | Founding Date 1958 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Shen Zhen Shi, CN HQ | Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US | Locations Danvers, US HQ Chiyoda City, JP Leiden, NL Leiden, NL Beverly, US Boston, US | Locations Mumbai, IN HQ | Locations HQ |
Employees | Employees 1,471 | Employees 26,015 | Employees 748 | Employees 5,3971% increase | Employees 4,6761% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥1b (FY, 2024) | Revenue (est.) ₹287b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥681.6m (FY, 2024) | Cost of goods ₹132.4b (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥373.1m (FY, 2024) | Gross profit ₹159.7b (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥13.8m (FY, 2024) | Net income ₹31.7b (FY, 2024) | Net income N/A | Net income N/A | Net income N/A |
Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.
View companyCell Signaling Technology develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents.
View companyUSV is a pharmaceutical and biotechnology company.
View companyLibbs Farmaceutica is a pharmaceutical company.
View company